597 related articles for article (PubMed ID: 24359019)
1. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.
Vo DD; Tran TP; Staedel C; Benhida R; Darfeuille F; Di Giorgio A; Duca M
Chemistry; 2016 Apr; 22(15):5350-62. PubMed ID: 26928593
[TBL] [Abstract][Full Text] [Related]
3. Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis.
Vo DD; Becquart C; Tran TPA; Di Giorgio A; Darfeuille F; Staedel C; Duca M
Org Biomol Chem; 2018 Aug; 16(34):6262-6274. PubMed ID: 30116813
[TBL] [Abstract][Full Text] [Related]
4. Design of Multimodal Small Molecules Targeting miRNAs Biogenesis: Synthesis and In Vitro Evaluation.
Vo DD; Duca M
Methods Mol Biol; 2017; 1517():137-154. PubMed ID: 27924480
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule approaches toward the targeting of oncogenic miRNAs: roadmap for the discovery of RNA modulators.
Di Giorgio A; Tran TP; Duca M
Future Med Chem; 2016 May; 8(7):803-16. PubMed ID: 27149207
[TBL] [Abstract][Full Text] [Related]
6. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Shi Z; Zhang J; Qian X; Han L; Zhang K; Chen L; Liu J; Ren Y; Yang M; Zhang A; Pu P; Kang C
Cancer Res; 2013 Sep; 73(17):5519-31. PubMed ID: 23811941
[TBL] [Abstract][Full Text] [Related]
7. Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer.
Pavithra D; Sabitha K; Rajkumar T
Comput Biol Chem; 2018 Dec; 77():442-454. PubMed ID: 30100328
[TBL] [Abstract][Full Text] [Related]
8. Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
Tran TP; Vo DD; Di Giorgio A; Duca M
Bioorg Med Chem; 2015 Sep; 23(17):5334-44. PubMed ID: 26264847
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer.
Wang J; Wang Q; Liu H; Hu B; Zhou W; Cheng Y
Cancer Lett; 2010 Nov; 297(2):137-43. PubMed ID: 20797817
[TBL] [Abstract][Full Text] [Related]
10. Aryl amide small-molecule inhibitors of microRNA miR-21 function.
Naro Y; Thomas M; Stephens MD; Connelly CM; Deiters A
Bioorg Med Chem Lett; 2015 Nov; 25(21):4793-4796. PubMed ID: 26220158
[TBL] [Abstract][Full Text] [Related]
11. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
Disney MD; Angelbello AJ
Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
[TBL] [Abstract][Full Text] [Related]
12. Approved Anti-cancer Drugs Target Oncogenic Non-coding RNAs.
Velagapudi SP; Costales MG; Vummidi BR; Nakai Y; Angelbello AJ; Tran T; Haniff HS; Matsumoto Y; Wang ZF; Chatterjee AK; Childs-Disney JL; Disney MD
Cell Chem Biol; 2018 Sep; 25(9):1086-1094.e7. PubMed ID: 30251629
[TBL] [Abstract][Full Text] [Related]
13. Modulation of oncogenic miRNA biogenesis using functionalized polyamines.
Staedel C; Tran TPA; Giraud J; Darfeuille F; Di Giorgio A; Tourasse NJ; Salin F; Uriac P; Duca M
Sci Rep; 2018 Jan; 8(1):1667. PubMed ID: 29374231
[TBL] [Abstract][Full Text] [Related]
14. Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance.
Li X; Luo F; Li Q; Xu M; Feng D; Zhang G; Wu W
Oncol Rep; 2011 Dec; 26(6):1431-9. PubMed ID: 21874264
[TBL] [Abstract][Full Text] [Related]
15. Identification of inhibitors of microRNA function from small molecule screens.
Connelly CM; Deiters A
Methods Mol Biol; 2014; 1095():147-56. PubMed ID: 24166310
[TBL] [Abstract][Full Text] [Related]
16. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
[TBL] [Abstract][Full Text] [Related]
17. A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing.
Shortridge MD; Walker MJ; Pavelitz T; Chen Y; Yang W; Varani G
ACS Chem Biol; 2017 Jun; 12(6):1611-1620. PubMed ID: 28437065
[TBL] [Abstract][Full Text] [Related]
18. [Application of microRNAs to Cancer Therapy].
Iguchi H; Ochiya T
Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672
[TBL] [Abstract][Full Text] [Related]
19. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1.
Zhuang M; Gao W; Xu J; Wang P; Shu Y
Biochem Biophys Res Commun; 2014 Jun; 448(3):315-22. PubMed ID: 24388988
[TBL] [Abstract][Full Text] [Related]
20. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
Ding L; Xu Y; Zhang W; Deng Y; Si M; Du Y; Yao H; Liu X; Ke Y; Si J; Zhou T
Cell Res; 2010 Jul; 20(7):784-93. PubMed ID: 20548334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
